ZORBAX StableBond 300 C8, 1 x 50 mm, 3.5 µm. A reversed-phase C8 HPLC column with fully porous ZORBAX particles. StableBond technology ensures stability at low pH.
Specifications:
Brand: ZORBAX 300SB-C8
Hardware: SS
Inner Diameter (ID): 1 mm
LC Platform: Stainless Steel
Length: 50 mm
Maximum Temperature: 80 °C
Part Number Application Domain: Biopharma
Part Number Application: Monoclonal Antibodies (mABs)PeptidesProteins
Particle Size: 3.5 µm
Particle Type: Fully Porous
Phase: 300SB-C8
Pore Size: 300 Å
Pressure Rating: 400 bar
Separation Mode: Reversed Phase
Shipping Solvent: Acetonitrile/Water
Technique: LCLC & LC/MS
UNSPSC Code: 41115709
pH Range: 1-8
**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
Designed for robust and reliable reversed-phase chromatography, this high-performance column features a 1 x 50 mm dimension packed with 3.5 micron particle size. Engineered with StableBond 300 C8 chemistry, it delivers enhanced durability and stability at low pH, making it ideal for the analysis and purification of peptides, proteins, and other biomolecules, especially those with moderate hydrophobicity. The wide-pore 300 angstrom silica offers superior resolution and reproducibility for large molecule separations, ensuring precise and consistent results in proteomics, biopharmaceutical R and D, or QC laboratories. This column is well-suited for use with a wide range of HPLC and UHPLC systems from Agilent as well as third-party compatible instruments. It integrates seamlessly with Agilent’s 1100 and 1200 series LC systems and is recommended for workflows involving peptide mapping, protein characterization, and method development for biotherapeutics. For optimal performance, the use of compatible StableBond columns or other ZORBAX phases for method scaling and development is advised. This column ensures long column lifetimes, high sample throughput, and reliable data generation for demanding analytical applications.